TUCCINARDI, DARIO
 Distribuzione geografica
Continente #
AS - Asia 3.545
NA - Nord America 1.219
EU - Europa 622
SA - Sud America 260
AF - Africa 34
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.692
Nazione #
SG - Singapore 2.634
US - Stati Uniti d'America 1.160
CN - Cina 427
IT - Italia 326
BR - Brasile 180
HK - Hong Kong 175
VN - Vietnam 110
FR - Francia 75
GB - Regno Unito 73
BD - Bangladesh 68
DE - Germania 43
IN - India 38
AR - Argentina 30
CA - Canada 26
NL - Olanda 26
MX - Messico 23
TR - Turchia 17
ID - Indonesia 14
UA - Ucraina 12
EC - Ecuador 11
AU - Australia 10
ZA - Sudafrica 10
AT - Austria 8
PE - Perù 8
CL - Cile 7
CO - Colombia 7
EE - Estonia 7
MA - Marocco 7
MD - Moldavia 7
MY - Malesia 7
PH - Filippine 7
RU - Federazione Russa 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
ES - Italia 6
FI - Finlandia 6
IQ - Iraq 6
SA - Arabia Saudita 6
TN - Tunisia 6
CZ - Repubblica Ceca 5
JP - Giappone 5
VE - Venezuela 5
JM - Giamaica 4
PK - Pakistan 4
PL - Polonia 4
DZ - Algeria 3
NP - Nepal 3
PY - Paraguay 3
RO - Romania 3
BO - Bolivia 2
CH - Svizzera 2
GT - Guatemala 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
RS - Serbia 2
SE - Svezia 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GM - Gambi 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KR - Corea 1
LT - Lituania 1
MM - Myanmar 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 5.692
Città #
San Jose 379
Singapore 292
Ashburn 265
Rome 207
Hong Kong 174
Beijing 108
Hefei 108
Lauterbourg 64
Boardman 56
Dallas 53
London 50
New York 38
Ho Chi Minh City 37
Los Angeles 30
Santa Clara 27
Council Bluffs 23
Shanghai 23
São Paulo 22
Hanoi 18
San Francisco 18
Mexico City 11
Milan 10
Munich 10
Toronto 10
Amsterdam 9
Curitiba 9
Frankfurt am Main 9
Las Vegas 9
Boston 8
Chennai 8
Orem 8
Pune 8
Rio de Janeiro 8
Washington 7
Biên Hòa 6
Da Nang 6
Guangzhou 6
Sydney 6
Brno 5
Buenos Aires 5
Campinas 5
Changsha 5
Chicago 5
Florence 5
Guayaquil 5
Haiphong 5
Johannesburg 5
Lima 5
Manchester 5
Quito 5
Tokyo 5
Ankara 4
Atlanta 4
Brooklyn 4
Buffalo 4
Bắc Giang 4
Can Tho 4
Montreal 4
Monza 4
Phoenix 4
Santiago 4
Turku 4
Vienna 4
Zhengzhou 4
Abu Dhabi 3
Birmingham 3
Bologna 3
Catania 3
Coimbatore 3
Denver 3
Hangzhou 3
Hanover 3
Lahore 3
Montevideo 3
Nanjing 3
Naples 3
Natal 3
New Delhi 3
Nuremberg 3
Porto Alegre 3
Quezon City 3
Rho 3
San Isidro 3
Secaucus 3
Shijiazhuang 3
Staten Island 3
Thái Nguyên 3
Tunis 3
Verona 3
Vitória 3
Wuhan 3
Agadir 2
Aracaju 2
Baghdad 2
Belo Horizonte 2
Blumenau 2
Bogotá 2
Botucatu 2
Brasília 2
Brescia 2
Totale 2.356
Nome #
A Novel Insulin Unit Calculator for the Management of Type 1 Diabetes 247
A 6-month follow-up study of the randomized controlled Ma-Pi macrobiotic dietary intervention (MADIAB trial) in type 2 diabetes 240
BMI and BMD: The Potential Interplay between Obesity and Bone Fragility 233
A pocket instrument for calculating insulin need in the management of type 1 diabetes 232
Blue eyes as a risk factor for type 1 diabetes 227
DiaPep277 peptide therapy in the context of other immune intervention trials in type 1 diabetes 220
Branched-Chain Amino Acids in relation to food preferences and insulin resistance in obese subjects consuming walnuts: A cross-over, randomized, double-blind, placebo-controlled inpatient physiology study 198
Treatment of reactive hypoglycemia with the macrobiotic Ma-pi 2 diet as assessed by continuous glucose monitoring: The MAHYP randomized crossover trial 156
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 153
Attitudes, weight stigma and misperceptions of weight loss strategies among patients living with obesity in the Lazio Region, Italy 144
A Ketogenic Diet Followed by Gradual Carbohydrate Reintroduction Restores Menstrual Cycles in Women with Polycystic Ovary Syndrome with Oligomenorrhea Independent of Body Weight Loss: Results from a Single-Center, One-Arm, Pilot Study 144
A bone metabolism evaluation in type 1 diabetes 142
A case of pheochromocytoma with negative MIBG scintigraphy, PET-CT and genetic tests (VHL included) and a rare case of post-operative erectile dysfunction 141
The psychological impact of COVID-19 pandemic on patients included in a bariatric surgery program. 137
An extra virgin olive oil-enriched chocolate spread positively modulates insulin-resistance markers compared with a palm oil-enriched one in healthy young adults: A double-blind, cross-over, randomised controlled trial 134
Bone density and genomic analysis unfold cold adaptation mechanisms of ancient inhabitants of Tierra del Fuego 128
Current Evidence to Propose Different Food Supplements for Weight Loss: A Comprehensive Review 117
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 112
Glycemic variability in the development of cardiovascular complications in diabetes 109
Women with type 1 diabetes gain more weight during pregnancy compared to age-matched healthy women despite a healthier diet: a prospective case–control observational study 101
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 98
Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity 94
Could ketogenic diet "starve" cancer? Emerging evidence 79
Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine 78
Scientific evidence underlying contraindications to the ketogenic diet: An update 78
Erectile dysfunction and its management in patients with diabetes mellitus 78
Vitamin K and osteoporosis: Myth or reality? 77
Sex difference in the safety and efficacy of bariatric procedures: a systematic review and meta-analysis 73
Effects of diet and antihyperglycemic drugs on erectile dysfunction: A systematic review 72
Predictors of weight loss in patients with obesity treated with a Very Low-Calorie Ketogenic Diet 72
The Mediterranean diet increases glucagon-like peptide 1 and oxyntomodulin compared with a vegetarian diet in patients with type 2 diabetes: A randomized controlled cross-over trial 69
Rapid Weight Loss, Central Obesity Improvement and Blood Glucose Reduction Are Associated with a Stronger Adaptive Immune Response Following COVID-19 mRNA Vaccine 63
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 63
Impact of a very low-calorie ketogenic diet on metabolic and microbiota outcomes in post-bariatric patients and bariatric-Naïve individuals: A comparative pilot study 62
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial 62
Hypoglycemia and its management in primary care setting 61
Exposure to artificial light at night: A common link for obesity and cancer? 58
Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19 55
The gastro-jejunal anastomosis site influences dumping syndrome and weight regain in patients with obesity undergoing Laparoscopic Roux-en-Y Gastric Bypass 53
Liver disease in obesity and underweight: the two sides of the coin. A narrative review. 52
The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study 51
Rethinking weight loss treatments as cardiovascular medicine in obesity, a comprehensive review 50
Postbariatric surgery hypoglycemia: Nutritional, pharmacological and surgical perspectives 49
Un calcolatore della dose di insulina nel management del diabete di tipo 1 49
Very Low-Calorie Ketogenic Diets to Treat Patients With Obesity and Chronic Kidney Disease 48
Obesity in type 1 diabetes: an overlooked immune-metabolic issue 45
Overweight and obese patients with nickel allergy have a worse metabolic profile compared to weight matched non-allergic individuals 44
Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease 44
Obesity and SARS-CoV-2: A population to safeguard 44
Sleep disturbances: one of the culprits of obesity-related cardiovascular risk? 44
SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness 42
Low-risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis 42
Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication 40
No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetesThe IMDIAB XIII trial 40
Spot-light on microbiota in obesity and cancer 39
AI-Powered Insulin Pens for Pediatric Diabetes: Advancements in Lipodystrophy Detection and Injection Site Recognition 36
Very Low-Calorie Ketogenic Diet: A Safe and Effective Tool for Weight Loss in Patients with Obesity and Mild Kidney Failure 31
Obesity treatment within the Italian national healthcare system tertiary care centers: what can we learn? 29
Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study 27
Development of the Italian clinical practice guideline on diagnosing and treating obesity in adults: scope and methodological aspects 26
Research advances in metabolism 2016 25
Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature 25
The overweight and obesity landscape in italy: data from the Italy cohort of the multi-country IMPACT-O study 24
Obesity and its management in primary care setting 23
Recommendations for the Management of Diabetes During Ramadan Applying the Principles of the ADA/ EASD Consensus: Update 2025 22
Walnut consumption increases activation of the insula to highly desirable food cues: A randomized, double‐blind, placebo‐controlled, cross‐over fMRI study 20
Mechanisms underlying the cardiometabolic protective effect of walnut consumption in obese people: A cross‐over, randomized, double‐blind, controlled inpatient physiology study 19
Mangosteen Extract Shows a Potent Insulin Sensitizing Effect in Obese Female Patients: A Prospective Randomized Controlled Pilot Study 19
Lorcaserin treatment decreases body weight and reduces cardiometabolic risk factors in obese adults: A six‐month, randomized, placebo‐controlled, double‐blind clinical trial 18
Very low‐calorie ketogenic diet and liraglutide as a synergistic strategy for the treatment of obesity: A short‐term, non‐randomised, observational, real‐world clinical evaluation 18
Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan 3
Real-world prescriptions of GLP-1RAs and SGLT2is in type 2 diabetes prioritise BMI and age over cardiorenal risk: a machine learning-based large cohort analysis 2
GLP-1 and GIP Beyond Glycaemia: Evolutionary Roles in Energy Optimisation and Organ Protection 2
Correction: Development of the Italian clinical practice guideline on diagnosing and treating obesity in adults: scope and methodological aspects 2
Personalizing bariatric metabolic surgery: Predictors of weight-loss success and risk of weight recurrence 1
Italian clinical practice GRADE-based guidelines on the diagnosis and treatment of overweight and obesity, endorsed by the Italian National Institute of Health 1
Beyond Weight Loss: Obesogenic Memory as Biological Hysteresis in Adipose Tissue Revealed by AI Semantic Mapping With an Exportable Core Corpus 1
The Burden of Obesity and Type 1 Diabetes: Distinct and Synergistic Effects to Worsen Perceived Health and Psychosocial Distress 1
Evolving kidney disease phenotypes in type 2 diabetes: declining albuminuria and increasing isolated low eGFR 1
Totale 5.759
Categoria #
all - tutte 27.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.003


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202256 0 0 1 0 0 0 0 0 9 1 0 45
2022/202350 1 0 16 5 7 2 2 2 2 0 11 2
2023/2024166 8 13 7 12 22 75 5 1 4 6 4 9
2024/20252.833 26 40 101 12 14 29 28 42 141 203 960 1.237
2025/20262.654 170 112 159 256 211 150 705 128 240 276 142 105
Totale 5.759